Skip to main content
. 2016 Oct 24;57(6):408–416. doi: 10.4111/icu.2016.57.6.408

Table 1. Demographic data and success rate comparisons between stenting and stentless groups for the total cohort.

Variable Total cohort (n=680) Stenting group (n=57) Stentless group (n=623) p-value
Age (y) 52.18±14.33 56.86±14.10 51.75±14.29 0.010a
Sex 0.873b
 Male 442 (65.0) 36 (63.2) 406 (65.2)
 Female 238 (35.0) 21 (36.8) 217 (34.8)
MSL (mm) 9.22±3.92 12.03±6.02 8.96±3.57 <0.001a
SSD (cm) 110.50±19.22 105.90±24.84 110.00±18.58 0.135a
MSD (HU) 708.04±272.19 717.86±285.06 707.14±271.20 0.776a
SHI (HU) 242.22±108.47 237.89±121.75 242.62±107.27 0.753a
Prior stone episodes 0.763b
 FSF 483 (71.0) 39 (68.4) 444 (71.3)
 RSF 197 (29.0) 18 (31.6) 179 (28.7)
Stone location 0.482b
 Upper 554 (81.5) 46 (80.7) 508 (81.5)
 Middle 48 (7.0) 6 (10.5) 42 (6.7)
 Lower 78 (11.5) 5 (8.8) 73 (11.7)
Stone laterality 0.610b
 Right 324 (47.6) 29 (50.9) 295 (47.4)
 Left 356 (52.4) 28 (49.1) 328 (52.6)
Complication rate 25 (3.7) 23 (3.7) 2 (3.5) 1.000
 Pyelonephritis 1 (0.1) 1 (0.2) 0 (0.0)
 Hematuria 2 (0.3) 2 (0.3) 0 (0.0)
 Colic pain 21 (3.1) 19 (3.0) 2 (3.5)
 GI symptoms 1 (0.1) 1 (0.2) 0 (0.0)
One-session success 476 (70.0) 28 (49.1) 448 (71.9) <0.001b

Values are presented as mean±standard deviation or number (%).

MSL, maximal stone length; SSD, skin-to-stone distance; MSD, mean stone density; SHI, stone heterogeneity index; FSF, first-time stone formers; RSF, recurrent stone formers; HU, Hounsfield units.

a:Based on Student or Welch's two-sample t-tests. b:Based on Pearson chi-square tests with Yates' continuity correction.